Client’s Testimonial:
“I am extremely thankful for all support that you/your team extended to me.”
On April 1st, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Researcher in the Field of Molecular Oncology (Approval Notice).
General Field: Molecular Oncology
Position at the Time of Case Filing: Researcher
Country of Origin: Nepal
State of Residence at the Time of Filing: California
Approval Notice Date: April 1st, 2021
Processing Time: 10 months, 13 days
Case Summary:
A researcher approached North America Immigration Law Group for filing an NIW (National Interest Waiver) petition on his behalf. Our client held a Ph.D. in molecular oncology. His knowledge, experience, expertise, and documented report of achievements have altogether made him an ideal candidate for the EB-2 NIW petition. Part of our job was to persuade USCIS that his research is nationally important and to highlight the use of his innovative methodologies and the essence of his breakthroughs. Hence, we included the following details in his NIW petition packet:
1) We detailed his research on identifying novel genes and genetic pathways to support the development of advanced prognostic and therapeutic methods for metastatic cancer, particularly glioblastomas and brain, breast, and lung cancers. After a complete review, we concluded that as cancer is a widespread disease in the United States, our client’s research is certainly of great importance because it is relevant to the treatment of metastatic cancer and the reduction of cancer mortality in the United States.
2) Also, we recorded that his publications accumulated 183 citations, confirming the great impact of his widespread recognition as a leading authority in the field of molecular oncology, and his publications included 6 peer-reviewed journal articles including two first authored publications. These papers have been published in the top journals in his chosen field, reflecting his peers’ appreciation of his work. His expert peers have directly utilized his models, referred to his work, and listed his findings as essential for others to look to for a greater understanding.
To further verify our client’s provided declarations, we advised him to reach out to other experts in the field for supporting his case, and successfully, he obtained two recommendation letters, adding more insights into the merit of his research work.
Our unique strategies were once again proved successful as we were able to convince USCIS of our client’s intent to continue researching cancer epigenetics, and we also stated how he has applied to several research positions at various U.S. institutions; thus, he is a valuable resource to the United States.
We are glad that our client received his NIW approval within 10 months and 13 days without any further request for evidence from USCIS. We thank him for associating with us and congratulate him on this great milestone.
North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).
Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend
With more than 16,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.
We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours
With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.
Vast Majority of Clients Came to Us Because of Referrals
For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 3,500 in 2019.
![](https://www.wegreened.com/blog/wp-content/uploads/2020/03/approval_table_2020.jpg)
If you are interested in filing the green card, please send your CV to law@wegreened.com for our free evaluation. Our attorneys will email you back with the evaluation result within 24 hours.
Approval Notices: https://www.wegreened.com/eb1_niw_approvals
Success Stories: https://www.wegreened.com/blog/
Website: www.wegreened.com
Free evaluation email: law@wegreened.com
Tel: 888.666.0969 (Toll Free)
To see more clients’ testimonials and approvals, please refer to:
To Learn More About Your Options CLICK HERE
Copyright © North America Immigration Law Group – WeGreened.com, All Rights Reserved.